在心脏手术中未被诊断的第七因子缺乏症因出血而复杂化:一个病例报告
Ziyad O Knio1, Mickey S Ising2, Kenan W Yount2
1From the Department of Anesthesiology.
A&A practice
|September 8, 2023
概括
罕见的VII因子缺乏症需要在手术期间进行特定的治疗. 复合因子VIIa有效控制心胸患者手术后出血,尽管最初的诊断挑战.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 麻醉学 麻醉学
背景情况:
- 罕见的出血障碍需要量身定制的术后复苏.
- 缺乏VII因子是一种罕见的凝血病,可以使手术过程复杂化.
- 复合因子VIIa (rFVIIa) 是一种激活的凝血因子,用于治疗严重出血.
研究的目的:
- 描述心胸外科手术患者未被诊断的单独的因子VII缺乏症的成功管理.
- 在这个特定的背景下,强调rFVIIa在控制严重的手术后出血方面的有用性.
主要方法:
- 一个心胸外科手术患者的病例报告,患有显著的术后出血.
- 用复合因子VIIa来纠正凝血病.
- 对凝血参数的评估,包括EXTEM测定.
主要成果:
- 患者经历了严重的术后出血.
- 服用rFVIIa有效控制了出血.
- 在EXTEM试验中,未能发现潜在的VII因子缺乏.
结论:
- 复合因子VIIa可以成为治疗罕见的出血障碍的关键救援疗法,如手术环境中的因子VII缺乏.
- 这一案例强调了考虑特定因子缺陷的重要性,即使标准凝血测试看起来正常.
- 有针对性的因子替代对于管理外科手术期间出血并发症至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Disorders of Hemostasis
987
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
987
Anticoagulant Drugs: Low-Molecular-Weight Heparins
747
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
747
Extrinsic and Intrinsic Pathways of Hemostasis
8.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Esophageal Varices-II: Clinical Features and Management
94
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
94


